SEC EDGAR CompanyFacts fact · reporting period
Chemomab Therapeutics Ltd.: cashflow_investing
One fact, its scope and the complete path back to the official record.
Reported value
$-59.000k{"amount": -59000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}- Metric
- cashflow_investing
- Period
- 2020-01-01 – 2020-09-30
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:32:58.077439+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001534248/cashflow-investing/2020-09-30 (CIK, metric, reporting date)History
- supersedes {"amount": 85000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0001104659-20-125523)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.